Dr. Reddy’s & Alvotech Partner to Develop Biosimilar to Keytruda, Expanding Oncology Portfolio

Unknown Apr 02, 2026 1,050 Views

Dr. Reddy’s Laboratories Ltd. and Alvotech have entered into a strategic collaboration to co-develop a biosimilar candidate to Keytruda (pembrolizumab), marking a major milestone in oncology treatment accessibility. The partnership aims to accelerate biosimilar development, ensuring afforda...